Prospective, Randomized, Double‐Blind Assessment of Supramolecular Bakuchiol and Terminalia Chebula Extract for Facial Photoaging in Chinese Sensitive Skin Population Authors: Xuefang Shi, Yimeng Wang, Huihui Zhang, Tao Zhang Published: 2025 ABSTRACT ABSTRACTBackground and AimsAsian skin is more sensitive than Caucasian. When it comes to anti‐aging treatments, some classic actives like Retinoids, are not friendly to Asian skin due to irritation issues. Therefore, it becomes more important to research new active ingredients to address the aging concern of sensitive skin. To clinically assess the anti‐aging, skin soothing, barrier function improvement efficacy of one novel formulation containing supramolecular Bakuchiol and Terminalia chebula extract in Chinese sensitive skin population.MethodsA total of 34 sensitive skin subjects were enrolled in this clinical efficacy study. A routine consisting of twice daily topical applications of the test serum was followed for 28 days, evaluations were performed at baseline (D0) and after 8 h (T8h), 14 days (D14) and 28 days (D28) of using the regime. Objective skin assessment principles are skin sensitivity, barrier and aging. Sensitivity was evaluated by lactic acid sting test (LAST). Skin barrier evaluation, including transepidermal water loss (TEWL), a* value, and redness percentage. Aging evaluation, including wrinkle area, skin wrinkle (SEw), elasticity (R2), firmness (F4). As well as dermatologist evaluation of skin sensitivity and aging parameters and safety assessment.ResultsTEWL, a* value, redness percentage and mean score of LAST significantly reduced by 24.90%, 10.76%, 31.81%, 28.09%, respectively, and Dermatologist assessment significant decrease in facial redness, after 28 days of skin care treatment with the test serum. Wrinkle area, SEw, F4 significantly reduced by 16.06%, 16.71%, 25.60%, respectively, and Dermatologist assessment significant decrease in facial wrinkles, while R2 significantly increased by 23.04% after 28 days. No adverse events were reported.ConclusionsThe serum containing supramolecular Bakuchiol and Terminalia chebula extract achieved skin rejuvenation in sensitive skin by improving sensitive and aging skin. Introduction Sensitive skin is characterized by an increased reactivity to various physiological or pathological conditions. This condition often presents on the face with symptoms such as facial redness, itching, a burning or tingling sensation, and skin tightness [1, 2, 3]. These symptoms can be triggered by physical, chemical, psychological, and other factors, such as heightened skin sensitivity to cosmetics, cold, heat, and sunlight [4]. Sensitive skin is a common and frequently occurring skin disorder that may affect about 30%–50% of the global population. Persistent itching and erythema in different areas of the face will seriously affect patients' aesthetics and quality of life [5]. Recently, the number of individuals with sensitive skin has grown due to air pollution and the diverse use of cosmetics. Roughly 50% of people report experiencing sensitive skin, and this percentage is on the rise [1, 3, 6]. The incidence of sensitive skin in Chinese women was 36.10%, but the incidence of sensitive skin was different in different places, 43.02% in Shanghai; Guangzhou 22.39%, Beijing 17.12%; Yangzhou 44.92%, including: female 44.62%, male 45.49% [7]. Therefore, nursing sensitive skin is increasingly important. Skin aging is mainly caused by the joint action of internal and external factors. Endogenous aging includes free radicals, chronic inflammation and collagen damage, etc. At the same time, external factors also have a great impact, such as excessive exposure to sunlight, which will affect cell activity, reduce collagen and elastin synthesis and increase degradation, and also reduce the production of other extracellular matrix ECM components, resulting in skin thinning, dryness, laxity, decreased elasticity, uneven pigmentation and deepening wrinkles and other aging symptoms [8, 9, 10, 11]. With the increasing improvement of people's living standards, more and more people begin to pursue healthy and young skin. Skin aging is an important factor affecting facial rejuvenation. As sensitive skin with skin barrier disruption would have more prone to be reacted with oxidative stress factors such as UV and pollution, which could further lead to skin inflammation [12]. In addition, Kompaore et al. [13]. found that transepidermal water loss (TEWL) was higher in Asian skin than Caucasian skin, suggesting that Asian skin is more susceptible to sensitivity. KUANG Xin‐jue et al. [14]. studied the characteristics and aging patterns of facial skin of 1000 women aged 22 to 42 years old through a multidimensional noninvasive assessment. Fitting analysis revealed that there were differences in the aging process between sensitive skin and normal skin. The population with sensitive skin was categorized according to the aging stages, that is, onset stage (22–28 years old), primary stage (29–33 years old), and secondary stage (34–42 years old), with different skin characteristics in different stages. In the primary aging stage, multi‐dimensional skin indicators changed, and the skin texture gradually got worse. In the secondary aging stage, skin aging was the most serious. Topical retinoids are used effectively to prevent and treat skin aging issues [15, 16]. However, their notable skin‐related side effects are frequently reported and well‐documented in the literature [17, 18, 19]. These side effects typically manifest as cutaneous erythema, pruritus, peeling, stinging or burning, and sensitivity [17]. Bakuchiol has only recently gained attention as a topical anti‐aging compound. Bakuchiol is a meroternene that is derived from Psoralea corylifolia seeds. Bakuchiol was suggested to exhibit retinol‐like functions, as in a skin substitute model, both substances show similar gene expression patterns in vitro [20]. and an improvement of cutaneous photodamage in vivo [21]. S. Dhaliwal et al. [21]. study demonstrates that bakuchiol is comparable to retinol in its ability to improve photoaging and is better tolerated than retinol. Bakuchiol is promising as a more tolerable alternative to retinol. Terminalia chebula is a medicinal plant with diverse benefits. Its extract, validated in previous research, demonstrated notable anti‐oxidative, anti‐inflammatory and anti‐aging effects [22, 23, 24, 25]. Terminalia chebula not only as a restorative to diminish visible signs of existing damage but also as a preventative to help defend skin against damages caused by chronic exposure to environmental pollution, Manpreet Randhawa et al. [26]. study yielded statistically significant improvements in dermatologist scores and subject self‐assessments for skin texture, hydration, tone, firmness and radiance as compared to its placebo. It has great potential for sensitive skin. We hope to create a formula that not only enhances anti‐aging effects but also soothes the skin, improves barrier function and sensitivity issues. We designed a study that used Terminalia chebula extract to reduce skin redness and in combination with another mild anti‐wrinkle ingredient, supramolecular Bakuchiol, to provide a multi‐active and versatile effect, and carried out a 28‐day human clinical efficacy test. Clinical studies have proven that a formula containing supramolecular Bakuchiol and Terminalia chebula extract not only excels in anti‐aging effects but is also suitable for sensitive skin, improving barrier function and skin sensitivity; it not only does not cause skin redness, but also reduces skin redness. Materials and Methods Study Design The safety test was carried out in Pony Test Group Shanghai Co. Ltd. Before the study began, each participant signed an informed consent form. The 24‐h patch test protocol (No. BREOV78B3590655R7) has been approved by the Ethics Committee of Pony Testing International Group Shanghai Co. Ltd. A 4‐week clinical study was conducted at the SGS testing center. This clinical study was a double‐blind study. The protocol (HZCPCH230500100‐2_CN) was approved by the SGS Clinical Research Ethics Committee. Thirty‐four subjects, including 31 female subjects and three male subjects, aged 50.91 ± 8.18 years, Fitzpatrick skin type Ⅱ‐IV, sensitive skin, explained the benefits, risks and potential complications to the subjects, and obtained the informed written consent of the subjects. Research Product The test product was a serum formulated with 1.05% supramolecular Bakuchiol (Shenzhen Shanhai Innovation Technology Co. Ltd), the Bakuchiol (INCI: BAKUCHIOL, physicochemical form: liquid, supplier: Sytheon Corporation) concentration in the serum formula was 0.105%, and 0.153% Terminalia chebula extract (INCI: TERMINALIA CHEBULA EXTRACT, physicochemical form: powder, supplier: Ingredi Corporation). Safety Evaluation First, the product passed a 24‐h patch test in 30 subjects for safety evaluation to detect potential adverse reactions. Thirty sensitive skin subjects, including both females and males aged 28.5 ± 5.1 years, were enrolled in the patch test. Patches (Finn Chambers, 8 mm) containing 20 μL of the serum were applied to the upper back and removed after 24 h. When the test substance is the cosmetic product itself, negetive control was blank. Readings were taken at three time points: 30 min, 24 h, and 48 h post‐removal. The International Contact Dermatitis Research Group's criteria were used to assess the patch test results [27]. Clinical Research Subjects Inclusion Criteria Their clinical manifestations were pruritus, burning, tightness, facial erythema; Lactic acid test ≥ 3 points; participants with multiple fine lines on the face (e.g., around the eyes, forehead), static lines in the nasolabial fold area, sagging in the lower face, and fine lines or wrinkles around the eyes; the Tewameter measurement value of the cheek area on one side of the face is > 15 g/h/m2; all subjects voluntarily participated in this study and signed an informed consent form. Exclusion Criteria Subjects who received skin peeling or skin treatment within 3 months prior to taking part in the test; subjects who received immune suppressive therapy within 3 months before the test; subjects who received systemic steroid therapy or phototherapy within 1 month before the test; subjects who had used products with similar efficacy within the 2 weeks preceding the exclusion test were excluded to ensure an adequate washout period; subjects who were pregnant, breast‐feeding, or planning a pregnancy; subjects who had a history of cosmetic allergies or other serious allergies history; subjects with systemic diseases or severe skin diseases. 2.4.2 Methods Methods of Use Subjects applied the product twice daily, in the morning and evening. Each application involved 1 grams of the product, which were evenly distributed on the face and gently massaged until fully absorbed. All participants were given active medication, and no placebo was used in the study. This study design was chosen to avoid possible cross‐contamination or mix‐ups that could occur in split placebo or vehicle‐controlled designs. The design of this study focuses on the overall efficacy of the final product, specifically the improvement observed after use compared to before use, rather than investigating specific individual ingredients. Test Time Points Subjects were assessed at baseline, 8 h, 2 weeks and 4 weeks. Prior to each evaluation, subjects cleaned their faces with amino acid cleansers and dried them with lint‐free paper towels. They then sat quietly in a standardized environment with constant temperature (20–22°C) and humidity (40%–60%) for at least 20 min. During this time, subjects completed a self‐assessment questionnaire, after which the researcher conducted the instrumental tests. Lactic Acid Sting Test Laboratory technicians used 10% lactic acid solution and distilled water solution for sting test to evaluate the response level at different time periods. Panelists' stinging and burning reactions were recorded at 2.5 min and 5 min by using a scale from 0 to 3:0 = none, 1 = slight, 2 = moderate, and 3 = severe [28]. Repair Evaluation Methods Soothing Evaluation Methods VISA7 (Canfield Scientific, Parsippany, NJ, USA) was used to collect facial images, and Image Pro Plus (IPP) was used to analyze the skin red area. The improvement of skin redness was analyzed by the two parameters of the redness percentage and a* value of the skin red area at the cheek. The a* value and the redness percentage are suitable for the evaluation of the efficacy of soothing functional cosmetics [29]. During the measurement, the subjects closed their eyes in a relaxed state. Improvement of skin TEWL. The TEWL value is a suitable parameter for assessing the effectiveness of functional cosmetics. TEWL to assess skin barrier function with Tewameter® TM 300 (Courage + Khazaka Electronic, Köln, German). Tewameter measurement area: intersection between the middle of the eye and the middle of the nose (random side, met inclusion criteria) [30]. A positioning card is used to accurately determine the test location, ensuring that the test positions remain consistent across multiple time points. Anti‐Aging Evaluation Methods The improvement of wrinkles was analyzed by VISIA7 (Canfield Scientific, Parsippany, NJ, USA) facial image combined with IPP for skin wrinkle area and SEw value of Visioscan® VC20 plus (Courage + Khazaka Electronic, Köln, German). The wrinkle area ratio and SEw value parameters are suitable for the evaluation of the efficacy of anti‐aging functional cosmetics. VC20 plus measurement area: highest zygomatic bone (opposite to Tewameter measurement side) During the measurement, the subjects closed their eyes in a relaxed state [31]. Skin Elasticity and Firmness Methods The Cutometer® MPA 580 (Courage + Khazaka Electronic, Köln, German) has been used to measure the elasticity and firmness of the skin below the cheekbones. The Cutometer operates on the principles of suction and stretching. It deforms the skin using negative pressure, measures the skin's ability to recover from this deformation, and uses the gross elasticity parameter R2 (Ua/Uf) to represent the skin's elastic properties. The firmness parameter F4 is used to represent the skin's compactness [32]. Cutometer measurement area: intersection of the outer corner of the eye and the lower part of the nasal alar. During each test, a positioning card ensures that the same test position is consistently measured. Dermatologist Assessment Dermatologists evaluated the skin condition of the subjects. The facial skin condition was evaluated with a 0–9 rating standard, including five efficacy attributes: nasolabial folds, crow's feet, infraorbital wrinkles, Skin fullness, and skin redness [28]. Statistical Analysis The representative data are expressed as mean ± SD. The data were analyzed by SPSS 28.0, and the test data were tested for normal distribution. If the test data were normal distribution, the T test method was used for statistical analysis. If the test data is non‐normal distribution, the rank sum test method is used for statistical analysis. Rank sum test was used for statistical analysis of grade data. p values of < 0.05 were considered statistically significant. Results Safety Evaluation The results of patch test showed that none of the 30 subjects had skin adverse reactions, subjects indicating that the product had no skin adverse reactions to the human skin. In the 4‐week clinical study, no subjects had local redness, itching, tingling, erythema, wheal, edema, or systemic skin adverse reactions. It showed that the essence products tested were mild overall, indicating that it was safe and mild to use on sensitive skin. Improvement of Sensitive Skin Lactic Acid Sting Test Compared with the lactic acid sting test (D‐2) (Figure 1): 8 h after the use of the product, LAST score was significantly reduced by 17.45%; after 14 days of using the product, LAST score was significantly reduced by 15.32%; after 28 days of using the product, LAST score was significantly reduced by 28.09%. LAST score is not only a screening condition for sensitive skin population, but also a reference index to evaluate the level of skin tolerance. In this study, after 4 weeks of using serum, the experimental group of people can effectively improve the skin's LAST score, indicating that the use of skin barrier repair skin care products can effectively improve the skin's tolerance to irritation and reduce the skin's sensitivity to exogenous irritation, and the formula is mild and suitable for sensitive skin. Improvement in mean score of lactic acid sting test after treatment (***p < 0.001). Soothingness Compared with baseline, there were significant differences in cheek a* value and the proportion of red area at 8 h, 2 weeks and 4 weeks (p < 0.05). The results showed that after 8 h of using the product, the a* value of the skin red area in the cheek test area was significantly reduced by 3.57%, and the redness percentage was significantly reduced by 10.25%. After 14 days of using the product, the a* value of the skin red area in the cheek test area was significantly reduced by 6.02%, and the redness percentage was significantly reduced by 14.69%. After 28 days of using the product, the a* value of the skin red area in the cheek test area was significantly reduced by 10.76%, and the redness percentage was significantly reduced by 31.81% (Figure 2 and Figure 3). The smaller the a* value, the smaller the redness percentage, indicating that the skin redness decreased. This shows that the product has a soothing effect after 8 h of use, and continuous use for 4 weeks can achieve continuous improvement (Figure 4). Improvement in a* value after treatment (**p < 0.01, ***p < 0.001). Improvement in redness percentage after treatment (***p < 0.001). A serum containing Terminalia chebula extract and Supramolecular Bakuchiol reduces facial redness. A facial photo of a 59‐year‐old Chinese woman. Repair Compared with baseline, there were significant differences in TEWL values at 8 h, 2 weeks and 4 weeks (p < 0.05). The results showed that 8 h after the use of the product, the skin transepidermal water loss in the cheek test area was significantly reduced by 20.74%. After 14 days of using the product, the skin transepidermal water loss in the cheek test area was significantly reduced by 20.62%; after 28 days of using the product, the skin transepidermal water lossin the cheek test area was significantly reduced by 24.90% (Figure 5). The smaller the skin transepidermal water loss was measured by Tewameter® TM Hex, indicating that the skin barrier function was improved. This shows that the product has a repair effect after 8 h of use, and continuous use for 4 weeks can achieve continuous improvement. Improvement in transepidermal water loss after treatment (***p < 0.001). Improvement of Anti‐Aging Anti‐Wrinkle Compared with the baseline, there were significant differences in the wrinkle area and the SEw value of skin wrinkles in the cheek test area at 8 h, 2 weeks and 4 weeks (p < 0.05). The results showed that after 8 h of using the product, the proportion of fishtail area decreased significantly by 3.90%, and the SEw value of skin wrinkles in the cheek test area decreased significantly by 22.11%. After 14 days of using the product, the proportion of fishtail area was significantly reduced by 6.42%, and the SEw value of skin wrinkles in the cheek test area was significantly reduced by 12.06%. After 28 days of using the product, the proportion of fishtail area decreased significantly by 16.06%, and the SEw value of skin wrinkles in the cheek test area decreased significantly by 16.71% (Figure 6 and Figure 7). The smaller the wrinkle area ratio is, the smaller the SEw value is, indicating that the wrinkles are reduced. This shows that this product also has anti‐wrinkle effect after 4 weeks of use (Figure 8). Improvement in wrinkle area after treatment (**p < 0.01, ***p < 0.001). Improvement in SEw value after treatment (*p < 0.05). A serum containing Terminalia chebula extract and Supramolecular Bakuchiol reduces facial wrinkles. A facial photo of a 51‐year‐old Chinese woman. Skin Elasticity The Cutometer results demonstrated a significant increase in the R2 value after using the product for 8 h (17.71% increase), and this trend continued over 2 weeks (20.99% increase) and 4 weeks (23.04% increase). The differences were statistically significant compared to the baseline. An R2 value closer to 1 (100%) indicates more elastic skin, thus confirming the product's efficacy in enhancing skin firmness (Figure 9). Improvement in R2 value after treatment (***p < 0.001). Skin Firmness The Cutometer results showed a significant decrease in the F4 value after using the product for 8 h (13.68% decrease), and this trend continued over 2 weeks (22.04% decrease) and 4 weeks (25.60% decrease). The differences were statistically significant compared to the baseline. A lower F4 value indicates greater resistance to suction, reflecting improved skin firmness. This confirms the product's efficacy in enhancing skin firmness (Figure 10). Improvement in F4 value after treatment (***p < 0.001). Dermatologist Assessment of Improvement Skin Sensitivity and Aging Parameter The changes in the self‐assessment of the efficacy of the 8 h, the 2 weeks and the 4 weeks compared with the baseline are shown in Table 1. Participants noted that compared with the baseline, nasolabial folds score, crow's feet score, Infraorbital wrinkles, and skin redness score were significantly reduced. Compared with before using the product, 8 h after using the product, nasolabial folds score significantly decreased by 2.49%, crow's feet score significantly decreased by 6.15%, infraorbital wrinkles score significantly decreased by 6.57%, skin fullness score decreased by 0.37%, and skin redness score significantly decreased by 12.66%. After 14 days of using the product, nasolabial folds score significantly decreased by 2.85%, crow's feet score significantly decreased by 6.54%, infraorbital wrinkles score significantly decreased by 6.93%, skin fullness score decreased by 1.12%, and skin redness score significantly decreased by 11.35%. After 28 days of using the product, nasolabial folds score significantly decreased by 4.27%, crow's feet score significantly decreased by 6.92%, infraorbital wrinkles score significantly decreased by 7.66%, skin fullness score decreased by 1.87%, and skin redness score significantly decreased by 17.03%. Table 1Results of dermatologist evaluation.Evaluation itemMeanRate of change p valueD0T8hD14D28T8hD14D28T8hD14D28Nasolabial folds4.134.034.013.96−2.49%−2.85%−4.27%0.0160.008< 0.001Crow's feet3.823.593.573.56−6.15%−6.54%−6.92%< 0.001< 0.001< 0.001Infraorbital wrinkles4.033.763.753.72−6.57%−6.93%−7.66%< 0.001< 0.001< 0.001Skin fullness3.933.913.883.85−0.37%−1.12%−1.87%1.0000.2500.063Skin redness3.372.942.992.79−12.66%−11.35%−17.03%< 0.001< 0.001< 0.001John Wiley & Sons, Ltd. Results of dermatologist evaluation. Discussion This study examines the hypothesis that the serum can improve skin redness, enhance skin barrier function and reduce signs of skin aging. Its efficacy was evaluated through clinical efficacy testing, focusing on aging concerns in sensitive skin. By integrating dermatological and cosmetology, this research proposes a practical approach to addressing aging issues in sensitive skin types. The serum contains Terminalia chebula extract and supramolecular Bakuchiol, designed to restore the skin barrier, reduce neurovascular reactivity, manage inflammation, and enhance aesthetic conditions such as wrinkle reduction and skin firming. Based on existing studies, our results corroborate that this combination optimally benefits individuals with sensitive skin by improving barrier functions, reducing TEWL, alleviating inflammation, and improving firmness and wrinkles. Supramolecular Bakuchiol acts primarily on anti‐aging pathways, while Terminalia chebula extract focuses on inflammation and cellular senescence. As demonstrated in our team's previous research [33]. that supramolecular Bakuchiol enhances collagen production by promoting the gene transcription of COL1A1 and COL3A3, while it inhibits inflammatory factors by increasing the transcription of anti‐inflammatory genes [PTX3, ADAM33 and PDLIM1]. Conversely, Terminalia chebula extract can inhibit cell senescence by directly reducing the transcription of MAP4K2 or by decreasing the accumulation of inflammatory factors, such as CCL3. This complementary targeting is critical for sensitive skin, where unregulated inflammation exacerbates aging processes and conventional anti‐aging ingredients (e.g., Retinol, bakuchiol) often induce irritation [21, 34]. The integration of supramolecular technology further distinguishes this formulation by optimizing bakuchiol's delivery and efficacy. Lu Beibei et al. [27]. study that supramolecular bakuchiol could deliver bakuchiol to the epidermis and dermis of the skin, demonstrating good skin permeability and safety. The permeability of supramolecular bakuchiol was 4.17 times that of retinol and 3.48 times that of bakuchiol. Compared with bakuchiol and retinol, at 0.01% supramolecular bakuchiol could decrease TNF‐α activity (inhibition rate 20.16%), inhibit MMP content in cells (inhibition rate51.87%), promote collagen‐I production in human skin fibroblasts (promotion rate 75.11%). The expression levels of col 1a1a, col 1a1b, and col 1a2 genes were upregulated, which promotes collagen synthesis and exerts antiaging effects on the skin. Liu Guoliang et al. [35]. demonstrated that bakuchiol protects human skin fibroblasts (HSF) from medium‐wave ultraviolet (UVB) induced photoaging by enhancing COL I expression while suppressing MMP‐1 and MMP‐3, as shown in their UVB irradiation experiments. Yu Xi et al. [36]. tested Bakuchiol inhibits the mechanism of MMP promoting collagen production to improve the clinical manifestations. Importantly, the supramolecular delivery system reduces the required concentration of bakuchiol, minimizing potential irritancy while maintaining anti‐aging potency—a key advantage over conventional formulations that often rely on higher concentrations (e.g., 0.1% bakuchiol) associated with allergic contact dermatitis [34]. In the present study, after subjects had used this product for 28 days, We found that the wrinkle area, facial SEw value decreased significantly, skin elasticity R2 increased significantly, and skin tightness F4 enhanced significantly. Terminalia chebula extract ameliorates clinical phenomena by suppressing inflammation. Manpreet Randhawa et al. study that Terminalia chebula not only as a restorative to diminish visible signs of existing damage but also as a preventative to help defend skin against damages caused by chronic exposure to environmental pollution [26]. Terminalia chebula extract is reported to have anti‐inflammatory properties, allowing it to neutralize inflammatory factors in the M1 supernatant and reduce inflammation in HSF cells. Our team's prior research [33]. has demonstrated that Terminalia chebula extract anti‐inflammatory properties, which confirmed to reverse inflammaging in this model by downregulating p16, p21, and MMP‐1 while upregulating the production of Col‐1. In the present study, We found that a significant reduction in TEWL, skin erythema and LAST score was observed. Our formulation not only suitable for sensitive skin to pass the sensitive skin patch test, but also shows in TEWL that we have improved the barrier and improved the sensitive skin. Consequently, it can be inferred that the serum incorporating supramolecular Bakuchiol complexed with Terminalia chebula extract not only effectively enhances cutaneous barrier function, mitigates inflammation‐induced redness and tingling discomfort, and reduces sensory nerve sensitivity of the skin, but also synergistically amplifies anti‐aging efficacy. This combination demonstrably ameliorates symptoms associated with facial aging and dermal laxity by modulating collagen synthesis, reducing oxidative stress, and reinforcing extracellular matrix integrity through their complementary mechanisms. Conclusions Results demonstrated that the serum containing supramolecular Bakuchiol and Terminalia chebula extract achieved skin rejuvenation in sensitive skin by improving sensitive and aging facial skin. Improvement in facial skin condition was observed as early as the 8 h and continued to improve up to 4 weeks. The effects of the product on repairing sensitive skin are as follows: After 28 days of application, the transepidermal water loss (TEWL) value was significantly decreased by 24.90%, the a* value was significantly decreased by 10.76%, and the redness percentage was significantly decreased by 31.81%. Additionally, the mean score of LAST was significantly decreased by 28.09%, and Dermatologist assessment significant decrease in skin redness. Regarding anti‐aging effects, after 28 days of use, the proportion of fishtail area was significantly decreased by 16.06%, while the SEw value of skin wrinkles in the cheek test area was significantly decreased by 16.71%. Furthermore, the skin elasticity (R2 value) was significantly increased by 23.04% and the skin firmness (F4 value) was significantly decreased by 25.60%, and Dermatologist assessment significant decrease in facial wrinkles. Importantly, no adverse reactions were observed during patch testing conducted with thirty subjects, confirming that this product does not induce any negative responses on human skin. In conclusion, our formulation demonstrates both gentleness and efficacy in anti‐aging treatment while being suitable for sensitive skin. Author Contributions Conceptualization, Xuefang Shi, Yimeng Wang, Huihui Zhang, and Tao Zhang, methodology, Xuefang Shi, Yimeng Wang and Tao Zhang; software, Xuefang Shi and Yimeng Wang; validation, Yimeng Wang, Huihui Zhang, and Tao Zhang; formal analysis, Xuefang Shi, Yimeng Wang and Tao Zhang, investigation, Huihui Zhang, Xuefang Shi, Yimeng Wang and Tao Zhang, resources, Yimeng Wang and Tao Zhang; data curation, Xuefang Shi and Yimeng Wang; writing‐original draft preparation, Xuefang Shi; writing‐review and editing, Yimeng Wang and Tao Zhang, visualization, Xuefang Shi, supervision, Yimeng Wang and Tao Zhang; project administration, Xuefang Shi and Yimeng Wang; funding acquisition, Tao Zhang All authors have read and agreed to the published version of the manuscript. Conflicts of Interest The authors declare no conflicts of interest.